Numbers and rates* of reported cases† of acute hepatitis C, by demographic characteristics — United States, 2018–2022
Characteristics | 2018 No. | 2018 Rate* | 2019 No. | 2019 Rate* | 2020 No. | 2020 Rate* | 2021 No. | 2021 Rate* | 2022 No. | 2022 Rate* |
---|---|---|---|---|---|---|---|---|---|---|
Total § | 3,621 | 1.2 | 4,136 | 1.3 | 4,798 | 1.5 | 5,023 | 1.6 | 4,848 | 1.5 |
Age (years) | ||||||||||
0–19 | 81 | 0.1 | 63 | 0.1 | 57 | 0.1 | 67 | 0.1 | 54 | 0.1 |
20–29 | 1,310 | 3.0 | 1,262 | 2.9 | 1,230 | 2.8 | 1,045 | 2.5 | 945 | 2.2 |
30–39 | 1,070 | 2.6 | 1,347 | 3.2 | 1.526 | 3.5 | 1,551 | 3.5 | 1,585 | 3.6 |
40–49 | 494 | 1.3 | 664 | 1.7 | 820 | 2.1 | 901 | 2.3 | 872 | 2.2 |
50–59 | 366 | 0.9 | 442 | 1.1 | 578 | 1.4 | 696 | 1.7 | 699 | 1.7 |
≥60 | 295 | 0.4 | 358 | 0.5 | 586 | 0.8 | 753 | 1.0 | 693 | 0.9 |
Sex | ||||||||||
Male | 2,012 | 1.3 | 2,471 | 1.6 | 3,105 | 2.0 | 3,348 | 2.1 | 3,227 | 2.0 |
Female | 1,605 | 1.0 | 1,653 | 1.0 | 1,687 | 1.0 | 1,669 | 1.0 | 1,614 | 1.0 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native, non-Hispanic | 83 | 3.6 | 83 | 3.6 | 48 | 2.1 | 55 | 2.7 | 59 | 2.9 |
Asian/Pacific Islander, non-Hispanic | 29 | 0.1 | 36 | 0.2 | 76 | 0.4 | 67 | 0.3 | 67 | 0.3 |
Black, non-Hispanic | 231 | 0.6 | 267 | 0.7 | 458 | 1.1 | 561 | 1.4 | 615 | 1.5 |
White, non-Hispanic | 2,405 | 1.3 | 2,683 | 1.4 | 3,060 | 1.6 | 3,097 | 1.6 | 2,831 | 1.5 |
Hispanic | 280 | 0.5 | 350 | 0.6 | 415 | 0.7 | 549 | 0.9 | 582 | 1.0 |
Other | 123 | n/a | 146 | n/a | 180 | n/a | 195 | n/a | 217 | n/a |
Urbanicity ¶ | ||||||||||
Urban | 2,782 | 1.0 | 3,275 | 1.2 | 3,957 | 1.4 | 4,215 | 1.5 | 3,992 | 1.4 |
Rural | 676 | 1.6 | 720 | 1.7 | 757 | 1.7 | 790 | 1.7 | 831 | 1.8 |
HHS region** | ||||||||||
Region 1: Boston | 172 | 1.2 | 237 | 1.7 | 329 | 2.4 | 334 | 2.4 | 287 | 1.9 |
Region 2: New York | 332 | 1.2 | 405 | 1.4 | 455 | 1.6 | 371 | 1.3 | 442 | 1.5 |
Region 3: Philadelphia | 404 | 1.4 | 392 | 1.3 | 365 | 1.2 | 365 | 1.2 | 403 | 1.3 |
Region 4: Atlanta | 1,056 | 1.7 | 1,253 | 2.0 | 1,957 | 2.9 | 2,247 | 3.3 | 2,125 | 3.1 |
Region 5: Chicago | 977 | 1.9 | 1,053 | 2.0 | 902 | 1.7 | 835 | 1.6 | 709 | 1.3 |
Region 6: Dallas | 114 | 0.3 | 157 | 0.4 | 384 | 0.9 | 405 | 0.9 | 276 | 0.6 |
Region 7: Kansas City | 89 | 0.8 | 74 | 0.5 | 60 | 0.4 | 44 | 0.3 | 52 | 0.4 |
Region 8: Denver | 225 | 1.9 | 222 | 1.9 | 138 | 1.1 | 184 | 1.5 | 261 | 2.1 |
Region 9: San Francisco | 133 | 0.3 | 222 | 0.5 | 71 | 0.2 | 107 | 0.2 | 173 | 0.4 |
Region 10: Seattle | 119 | 0.9 | 121 | 0.9 | 137 | 1.0 | 131 | 0.9 | 120 | 0.9 |
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population. Beginning in 2021, single-race population estimates are used for rate calculations. For prior years, bridged-race population estimates are used. When comparing the 2021 and 2022 rates by race/ethnicity to prior years, differences may be due to the change in denominator and should be interpreted with caution (see Technical Notes).
† Reported confirmed cases. For the case definition, see Acute Hepatitis C.
§ Numbers reported in each category may not add up to the total number of reported cases in a year due to cases with missing data.
¶ Urbanicity was categorized according to the 2013 National Center for Health Statistics (NCHS) urban-rural classification scheme for counties and county-equivalent entities. Large central metro, large fringe metro, medium metro, and small metro counties were grouped as urban. Micropolitan and noncore counties were grouped as rural.
** US Department of Health and Human Services regions were categorized according to the grouping of states and US territories assigned under each of the 10 Health and Human Services regional offices. For the purposes of this report, regions with US territories (Region 2 and Region 9) contain data from states only.
n/a: Not applicable. Rate cannot be calculated due to lack of corresponding denominator.
This table summarizes the epidemiology of acute hepatitis C in the United States. During 2022, rates of acute hepatitis C were highest among persons aged 20–49 years, males, non-Hispanic American Indian/Alaska Native persons, and those living in US Department of Health and Human Services Region 4 (Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee).
Using urbanicity categories defined by the National Center for Health Statistics, rates of reported cases of acute hepatitis C remained consistently higher in rural settings compared with urban settings during 2018–2022. During 2021–2022, the rate in urban settings decreased, whereas the rate in rural settings increased. Among all acute hepatitis C cases reported during 2022, 52% occurred among persons aged 20–39 years, 65% occurred among non-Hispanic White persons, and 82% occurred in urban areas.
- Figure 3.1. Number of reported cases and estimated infections of acute hepatitis C — United States, 2015–2022
- Figure 3.2. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2021–2022
- Figure 3.3. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2022
- Figure 3.4. Rates of reported cases of acute hepatitis C, by age group — United States, 2007–2022
- Figure 3.5. Rates of reported cases of acute hepatitis C, by sex — United States, 2007–2022
- Figure 3.6. Rates of reported cases of acute hepatitis C, by race/ethnicity — United States, 2007–2022
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C — United States, 2022
- Figure 3.8. Number of newly reported chronic hepatitis C cases by sex and age — United States, 2022
- Figure 3.9. Rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 3.1. Numbers and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2018–2022
- Table 3.2. Numbers and rates of reported cases of acute hepatitis C, by demographic characteristics — United States, 2018–2022
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C — United States, 2022
- Table 3.4. Number of newly reported cases of perinatal hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C, by demographic characteristics — United States, 2022
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 3.8. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022